Manufacturer record
Aristo Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
20 batches manufactured by Aristo Pharmaceuticals Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between May 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
20 records linked to Aristo Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Gastro-resistant Tablets IP 40 mg | SPK251470Mfg 2025-10 · Exp 2028-03 | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab | Jul 2026 |
| Telmisartan Tablets IP 40 Mg | SPE250642Mfg 2025-05 · Exp 2027-04 | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan 40mg & Amlodipine 5mg Tablets IP | BPH252331Mfg 2025-08 · Exp 2027-07 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
| Pantoprazole Gastro Resistant Tablets IP 40mg | SPG240936Mfg 2024-07 · Exp 2026-12 | The sample does not conform to I.P. w.r.to the tests for Identification AssayAssay | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan & Amlodipine Tablets IP | BPF251519Mfg 2025-06 · Exp 2027-05 | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab | Apr 2026 |
| Pantoprazole & Domperidone Capsules IP | SPJ241197Mfg 2024-09 · Exp 2026-08 | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab | Apr 2026 |
| Cefpodoxime Tablets IP 200 Mg | BPA250167Mfg 2025-01 · Exp 2026-12 | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab | Apr 2026 |
| Pantoprazole Sodium Gastro-resistant and Domperidone Prolonged -release Capsules IP | SPA250021Mfg 2025-01 · Exp 2026-12 | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC and Assay of Pantoprazole Sodium calculated as Pantoprazole, Domperidone.Assay | RDTL,ChandigarhCDSCO lab | Nov 2025 |
| Telvas-AM (Telmisartan & Amlodipine Tablets I.P.) | BPG241 827Mfg 2024-07 · Exp 2026-06 | Does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Mar 2025 |
| Telvas H 40/12.5 (Telmisartan & Hydrochlorothiazide Tablets I.P.) | SPB240 306Mfg 2024-02 · Exp 2026-01 | Does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Mar 2025 |
| Telvas 40 (Telmisartan Tablets I.P. 40mg.) | SPB240 221Mfg 2024-02 · Exp 2026-01 | Does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Mar 2025 |
| Cefpodoxime Tablets IP 200 mg (Monocef-O 200) | BPH232520Mfg 2023-08 · Exp 2025-07 | Identification and Assay/ Content of CefpodoximeAssay | RDTL GuwahatiCDSCO lab | Sep 2024 |
| Cefpodoxime Tablets IP 200 mg (Monocef-O 200) | BPD231045Mfg 2023-04 · Exp 2025-03 | Identification and Assay/ Content of CefpodoximeAssay | RDTL GuwahatiCDSCO lab | Sep 2024 |
| Ceftraixone Injection IP (Monocef 500 mg) | MPD231319Mfg 2023-04 · Exp 2025-09 | Clarity of solutionOther | CDL KolkataCDSCO lab | Nov 2023 |
| Monocef - O (Cefpodoxime Tablets IP 200 mg) | BPH222546Mfg 2022-08 · Exp 2024-07 | Identification, Assay & Uniformity of weightAssay | CDL KolkataCDSCO lab | Feb 2023 |
| Pantop-DSR� (Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged- release Capsules IP) | SPA220030Mfg 2022-01 · Exp 2023-12 | Identification and Assay/ Content of ?Pantoprazole and Domperidone?Assay | RDTL GuwahatiState lab | Nov 2022 |
| Pantop- D SR� (Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged-release Capsules IP) | SPJ211372Mfg 2021-09 · Exp 2023-08 | Identification and Assay/Content of Pantoprazole & Domperidone and DescriptionAssay | RDTL GuwahatiState lab | Nov 2022 |
| Pantop-DSR (Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged release Capsules IP) | SPM211927Mfg 2021-12 · Exp 2023-11 | Identification and AssayAssay | RDTL GuwahatiState lab | Oct 2022 |
| Delisprin 75 (Aspirin Delayed Release Tablets U.S.P. 75 mg) | M107M018Mfg 2018-12 · Exp 2020-05 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2019 |
| Amlodipine Tablets IP 10 mg (AMLOSAFE 10 TABLETS) | M129L018Mfg 2018-11 · Exp 2020-10 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.